Company Profiles

driven by the PitchBook Platform

Targanox

Description

Developer of therapeutic drugs to prevent stress induced diseases. The company is focused on developing drugs to curb a disease-related biochemical condition called oxidative stress.

2008

Founded

PRIVATE

Status

Series A

Latest Deal Type

$5.1M

Latest Deal Amount

$5.1M

Total Amount Raised

2

Investors

Description

Developer of therapeutic drugs to prevent stress induced diseases. The company is focused on developing drugs to curb a disease-related biochemical condition called oxidative stress.

Website:

www.targanox.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Other Pharmaceuticals and Biotechnology

Primary Office

37 Spinelli Place Cambridge, MA 02138United States +1 (617) 245-4600
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Targanox's full profile, request a free trial.

    Targanox Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Targanox Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    Targanox Investors (2)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Ascent Biomedical VenturesVenture CapitalMinority000 0000000 0000
    Partners HealthCare InnovationCorporate Venture CapitalMinority000 0000000 0000
    Ascent Biomedical Ventures Venture Capital
    Partners HealthCare Innovation Corporate Venture Capital

    Targanox Executive Team (6)

    NameTitleBoard
    Seat
    Contact
    Info
    Ross Stein Ph.DChief Scientific Officer
    Joel Sandler Ph.DDirector, Business Development
    L. Gordon LettsCo-Founder & Chief Scientist
    Kate CarrollCo-Founder
    Avi Kometz MDChief Executive Officer & Board Member
    Ross Stein Ph.D Chief Scientific Officer
    Joel Sandler Ph.D Director, Business Development
    L. Gordon Letts Co-Founder & Chief Scientist
    Kate Carroll Co-Founder
    Avi Kometz MD Chief Executive Officer & Board Member

    Targanox Board Members (4)

    NameRepresentingRoleSinceContact
    Info
    Avi Kometz MDSelfChief Executive Officer & Board Member000 0000
    Geoffrey Smith JDAscent Biomedical VenturesCo-Founder, Managing Partner & General Partner000 0000
    Joseph Loscalzo Ph.DSelfCo-Founder & Board Member000 0000
    Roger KittermanPartners HealthcareManaging Partner000 0000
    Avi Kometz MD Chief Executive Officer & Board Member Self
    Geoffrey Smith JD Co-Founder, Managing Partner & General Partner Ascent Biomedical Ventures
    Joseph Loscalzo Ph.D Co-Founder & Board Member Self
    Roger Kitterman Managing Partner Partners Healthcare
    Request full access to PitchBook